Safety and Efficacy of ZM-02 Optogenetic Gene Therapy Clinical Study for Advanced Retinitis Pigmentosa (ARVO 2025) - Mar 26, 2025 - Abstract #511; Pres time: May 4, 2025; 02:00 PM - 02:15 PM; Location: Ballroom G; P1 | "Surprisingly, many treated patients also reported improvements in color vision. These results suggest that ZM-02 could be a new way to help people with advanced RP regain some of their vision and improve their quality of life."
Clinical • Gene therapy • Metastases • Inherited Retinal Dystrophy • Ocular Inflammation • Ophthalmology • Retinal Disorders • Retinitis Pigmentosa
|
|
Wenhui Zhou1; Menghan Zhou1; Mojtaba Shirinzadeh1; Haihan Zhang2; shiyi yin2; Jingyun Liu3; wenbin wei2; Yin Shen1,3
|